Question 1

What is SLC35A1-congenital disorder of glycosylation?

Accepted Answer

SLC35A1-congenital disorder of glycosylation (SLC35A1-CDG) is an extremely rare condition that falls under the group of congenital disorders of glycosylation (CDG). It is characterized by a defect in the CMP-sialic acid transporter, which plays a role in the proper glycosylation of proteins. Glycosylation is a process that helps attach sugars to proteins, which is important for their function.

The clinical information available comes from a single reported case, where individuals experienced repeated hemorrhagic incidents, including a severe pulmonary hemorrhage. This information highlights that the condition can have serious implications, although detailed knowledge is limited due to the rarity of the disorder.

Question 2

What are the symptoms of SLC35A1-congenital disorder of glycosylation?

Accepted Answer

In the reported case, people with SLC35A1-CDG experienced repeated bleeding incidents, including severe bleeding in the lungs. Information about other symptoms is limited due to the few cases reported.

Question 3

What causes SLC35A1-congenital disorder of glycosylation?

Accepted Answer

SLC35A1-CDG is linked to changes in the SLC35A1 gene. This gene is important for the transport of CMP-sialic acid, a molecule needed for glycosylation. The condition is caused by defects in this gene, which can lead to problems in the glycosylation process. Detailed risk factors and genetic mechanisms beyond this are not extensively described in the available information. Associated genes include SLC35A1.

Question 4

How is SLC35A1-congenital disorder of glycosylation inherited?

Accepted Answer

SLC35A1-congenital disorder of glycosylation follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is SLC35A1-congenital disorder of glycosylation?

Accepted Answer

SLC35A1-congenital disorder of glycosylation is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is SLC35A1-congenital disorder of glycosylation diagnosed?

Accepted Answer

Information about diagnosis is currently limited for this condition.

Question 7

Are there treatments for SLC35A1-congenital disorder of glycosylation?

Accepted Answer

Information about treatment options is currently limited for this condition.

Question 8

What complications can arise from SLC35A1-congenital disorder of glycosylation?

Accepted Answer

SLC35A1-congenital disorder of glycosylation can lead to serious complications, including repeated bleeding incidents. One reported case highlighted severe pulmonary hemorrhage, which is bleeding in the lungs. This shows that the condition can have serious health implications, although more information is needed to understand all potential complications.

Question 9

How does SLC35A1-congenital disorder of glycosylation affect daily life?

Accepted Answer

Living with SLC35A1-congenital disorder of glycosylation can be challenging due to the risk of bleeding incidents. Families may need to be cautious and monitor for any signs of bleeding, especially in the lungs. Daily life may involve regular check-ups and being aware of the symptoms to manage the condition effectively.

Question 10

What is the prognosis for someone with SLC35A1-congenital disorder of glycosylation?

Accepted Answer

Currently, there is limited information about the long-term prognosis for individuals with SLC35A1-congenital disorder of glycosylation. Since it is an extremely rare condition, detailed studies on life expectancy and outcomes are not available. Families may need to consult with specialists for personalized information and support.

Question 11

Are there any specialists recommended for SLC35A1-congenital disorder of glycosylation?

Accepted Answer

Due to the rarity of SLC35A1-congenital disorder of glycosylation, it is important to consult with specialists who have experience in congenital disorders of glycosylation. Geneticists and pediatricians familiar with rare diseases may provide valuable insights and management strategies. Families should seek out healthcare providers who understand the complexities of this condition.

Organ System	Phenotype Count	Example Features
Brain and nerves	9	Encephalopathy, Poor speech, Seizure
Blood and immune system	8	Recurrent bacterial infections, Decreased platelet glycoprotein Ib, Low platelet count (thrombocytopenia)
Lungs and breathing	4	Pulmonary hemorrhage, Pneumonia, Respiratory distress
Muscles	1	Generalized hypotonia
Eyes	1	Nystagmus
Head and neck	1	Microcephaly
Kidneys and urinary system	1	Protein in the urine (proteinuria)
Skin	1	Subcutaneous hemorrhage
Heart and blood vessels	1	Aortic regurgitation

Research Type	Count	% of Total
Laboratory research	126	53%
Research summaries	73	31%
Testing and diagnosis research	11	5%
New treatment approaches	11	5%
Disease patterns and progression	10	4%
Patient case studies	6	3%
Clinical study results	2	1%

Kisho

SLC35A1-congenital disorder of glycosylation

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

SLC35A1-congenital disorder of glycosylation

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is SLC35A1-congenital disorder of glycosylation?

What are the symptoms of SLC35A1-congenital disorder of glycosylation?

What causes SLC35A1-congenital disorder of glycosylation?

How is SLC35A1-congenital disorder of glycosylation inherited?

How rare is SLC35A1-congenital disorder of glycosylation?

How is SLC35A1-congenital disorder of glycosylation diagnosed?

Are there treatments for SLC35A1-congenital disorder of glycosylation?

What complications can arise from SLC35A1-congenital disorder of glycosylation?

How does SLC35A1-congenital disorder of glycosylation affect daily life?

What is the prognosis for someone with SLC35A1-congenital disorder of glycosylation?

Are there any specialists recommended for SLC35A1-congenital disorder of glycosylation?

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications